Former CFO of GSK joins Revolymer board

Richard Crump Hedge Funds Review AS A CONSEQUENCE of its admission to the AIM Market, UK polymer company Revolymer has appointed Julian Heslop to its board as a non-executive director. Heslop served as CFO of GlaxoSmithKline between April 2005 and March 2011

Richard Crump Hedge Funds Review

boardroom-table

AS A CONSEQUENCE of its admission to the AIM Market, UK polymer company Revolymer has appointed Julian Heslop to its board as a non-executive director. Heslop served as CFO of GlaxoSmithKline between April 2005 and March 2011. He was also Chairman of ViiV Healthcare until March 2011. He served as senior vice president, operations controller of GSK between January 2001 and March 2005 and as financial controller of Glaxo Wellcome from…


View original post here:
Former CFO of GSK joins Revolymer board

Author Bio

R K Consultancy